---
title: Mis-localization of endogenous TDP-43 leads to ALS-like early-stage metabolic
  dysfunction and progressive motor deficits
date: '2024-06-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38902734/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240621182551&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The new TDP-43 model mimics the ALS/FTLD hallmark of progressive
  motor dysfunction. Our results suggest that functional deficits of the hypothalamus,
  the metabolic regulatory center, might be the primary cause of weight loss in ALS
  patients. Cytoplasmic gain of function of endogenous TDP-43 leads to metabolic dysfunction
  in vivo that are reminiscent of early ALS clinical non-motor metabolic alterations.
  Thus, the CytoTDP zebrafish model offers a unique opportunity to ...'
disable_comments: true
---
CONCLUSIONS: The new TDP-43 model mimics the ALS/FTLD hallmark of progressive motor dysfunction. Our results suggest that functional deficits of the hypothalamus, the metabolic regulatory center, might be the primary cause of weight loss in ALS patients. Cytoplasmic gain of function of endogenous TDP-43 leads to metabolic dysfunction in vivo that are reminiscent of early ALS clinical non-motor metabolic alterations. Thus, the CytoTDP zebrafish model offers a unique opportunity to ...